封面
市场调查报告书
商品编码
1542632

全球生物製药辅料市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Biopharmaceutical Excipients Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: | 出版商: Value Market Research | 英文 131 Pages | 商品交期: 最快1-2个工作天内

价格

全球生物製药辅料市场需求预计将从 2023 年的 31.2 亿美元达到近 53.2 亿美元的市场规模,2024-2032 年研究期间复合年增长率为 6.12%。

生物製药辅料是配製生物製药产品(如疫苗、单株抗体和基因疗法)的惰性物质。它们具有多种功能,包括稳定活性成分、增强溶解度和改善药物传输。这些赋形剂可包括稳定剂、防腐剂和增溶剂等物质,对于确保生物製药的功效、安全性和品质至关重要。与传统药物中使用的赋形剂不同,它们必须满足严格的监管要求和相容性标准,以确保它们不会干扰活性药物成分 (API) 的生物活性。

市场动态

对生物製剂和先进疗法的需求不断增长,推动了生物製药辅料市场的发展。随着生物製药产业的扩张,对专用赋形剂的需求不断增长,以增强生物药物的稳定性、递送和功效。赋形剂在配製复杂的生物製剂(例如单株抗体和基因疗法)中发挥着不可或缺的作用,这些生物製剂需要客製化的赋形剂解决方案来维持产品品质和性能。辅料开发的技术进步正在市场中创造重大机会。新型稳定剂和先进的输送系统等赋形剂技术的创新正在改善生物製药产品的配方和製造。这些进步使得开发更有效、更安全的治疗方法成为可能,从而推动了对尖端辅料的需求。

对个人化医疗的日益关注也有助于生物製药辅料市场的成长。个人化治疗通常需要专门的赋形剂来解决独特的配方挑战并优化药物传递。这一趋势正在推动客製化辅料解决方案的开发,以支持不断发展的个人化医疗领域。监管的进步和对品质控制的日益重视进一步推动了生物製药辅料市场的发展。随着监管机构对生物製药生产实施更严格的指导方针,人们更加关注辅料的品质和合规性。这导致了对符合严格监管标准并确保产品安全性和有效性的辅料开发的投资增加。然而,高昂的研发成本和严格的监管要求可能会抑制市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具也对全球生物製药辅料市场的各个细分市场进行了包容性评估。生物製药辅料产业的成长和趋势为本研究提供了整体方法。

市场区隔

生物製药辅料市场报告的这一部分提供了国家和地区层面细分市场的详细资料,从而帮助战略家确定相应产品或服务的目标人群以及即将到来的机会。

按产品分类

  • 增溶剂及界面活性剂/乳化剂(三酸甘油酯、酯类、其他)
  • 多元醇(甘露醇、山梨醇、其他)
  • 碳水化合物(蔗糖、葡萄糖、淀粉、其他)

区域分析

本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲生物製药辅料市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。生物製药辅料市场的主要参与者包括默克公司、卡乐康、巴斯夫公司、英国联合食品公司、Signet Excipients Pvt.。 Ltd (IMCD)、Sigachi Industries Limited、Spectrum Chemical Manufacturing Corp.、Roquette FreRes、IMCD、科莱恩、DFE Pharma、J. Rettenmaier & SoHne GmbH + Co KG、Evonik Industries AG。本节包含竞争格局的整体视图,包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章:前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章:执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章:生物製药辅料 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品分類的市场吸引力分析
    • 市场吸引力分析:按地区

第 4 章:价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章:全球生物製药辅料市场分析:按产品

  • 概述(按产品)
  • 按产品分类的历史和预测资料分析
  • 增溶剂及界面活性剂/乳化剂(三酸甘油酯、酯类、其他)
  • 多元醇(甘露醇、山梨醇、其他)
  • 碳水化合物(蔗糖、葡萄糖、淀粉、其他)

第 6 章:全球生物製药辅料市场分析:依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 7 章:生物製药辅料公司的竞争格局

  • 生物製药辅料市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 8 章:公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Merck KGaA
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Colorcon
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • BASF SE
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Associated British Foods Plc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Signet Excipients Pvt. Ltd (IMCD)
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Sigachi Industries Limited
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Spectrum Chemical Manufacturing Corp.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Roquette FreRes
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • IMCD
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Clariant
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • DFE Pharma
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • J. Rettenmaier & SoHne GmbH + Co KG
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Evonik Industries AG
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中,财务详细资讯和最新发展视情况而定,或对私人公司而言可能不包括在内

Product Code: VMR11210576

The global demand for Biopharmaceutical Excipients Market is presumed to reach the market size of nearly USD 5.32 Billion by 2032 from USD 3.12 Billion in 2023 with a CAGR of 6.12% under the study period 2024-2032.

Biopharmaceutical excipients are inert substances that formulate biopharmaceutical products, such as vaccines, monoclonal antibodies, and gene therapies. They serve various functions, including stabilizing active ingredients, enhancing solubility, and improving drug delivery. These excipients can include substances like stabilizers, preservatives, and solubilizers, and are crucial in ensuring the efficacy, safety, and quality of biopharmaceuticals. Unlike excipients used in traditional pharmaceuticals, they must meet stringent regulatory requirements and compatibility standards to ensure they do not interfere with the biological activity of the active pharmaceutical ingredients (APIs).

Market Dynamics

The increasing demand for biologics and advanced therapeutics drives the biopharmaceutical excipients market. As the biopharmaceutical sector expands, there is a growing need for specialized excipients to enhance biologic drugs' stability, delivery, and efficacy. Excipients play an integral role in formulating complex biologics, such as monoclonal antibodies & gene therapies, which require tailored excipient solutions to maintain product quality and performance. Technological advancements in excipient development are creating significant opportunities within the market. Innovations in excipient technologies, such as novel stabilizers and advanced delivery systems, are improving the formulation and manufacturing of biopharmaceutical products. These advancements enable the development of more effective and safer therapeutics, driving demand for cutting-edge excipients.

The increasing focus on personalized medicine also contributes to biopharmaceutical excipients market growth. Personalized therapeutics often require specialized excipients to address unique formulation challenges and optimize drug delivery. This trend is driving the development of customized excipient solutions to support the growing field of personalized medicine. Regulatory advancements and a growing emphasis on quality control further drive the biopharmaceutical excipients market. As regulatory agencies impose stricter guidelines for biopharmaceutical manufacturing, there is a heightened focus on excipient quality and compliance. This has led to increased investment in the development of excipients that meet rigorous regulatory standards and ensure product safety and efficacy. However, high research and development costs and stringent regulatory requirements may restrain market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Biopharmaceutical Excipients. The growth and trends of Biopharmaceutical Excipients industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Biopharmaceutical Excipients market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Solubilizes & Surfactants/Emulsifiers (Triglycerides, Esters, Others)
  • Polyols (Mannitol, Sorbitol, Others)
  • Carbohydrates (Sucrose, Dextrose, Starch, Others)

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Biopharmaceutical Excipients market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Biopharmaceutical Excipients market include Merck KGaA, Colorcon, BASF SE, Associated British Foods Plc, Signet Excipients Pvt. Ltd (IMCD), Sigachi Industries Limited, Spectrum Chemical Manufacturing Corp., Roquette FreRes, IMCD, Clariant, DFE Pharma, J. Rettenmaier & SoHne GmbH + Co KG, Evonik Industries AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. BIOPHARMACEUTICAL EXCIPIENTS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Solubilizes & Surfactants/Emulsifiers (Triglycerides, Esters, Others) Historic and Forecast Sales By Regions
  • 5.4. Polyols (Mannitol, Sorbitol, Others) Historic and Forecast Sales By Regions
  • 5.5. Carbohydrates (Sucrose, Dextrose, Starch, Others) Historic and Forecast Sales By Regions

6. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS BY GEOGRAPHY

  • 6.1. Regional Outlook
  • 6.2. Introduction
  • 6.3. North America Sales Analysis
    • 6.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.3.2 North America By Segment Sales Analysis
    • 6.3.3 North America By Country Sales Analysis
    • 6.3.4 United States Sales Analysis
    • 6.3.5 Canada Sales Analysis
    • 6.3.6 Mexico Sales Analysis
  • 6.4. Europe Sales Analysis
    • 6.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.4.2 Europe By Segment Sales Analysis
    • 6.4.3 Europe By Country Sales Analysis
    • 6.4.4 United Kingdom Sales Analysis
    • 6.4.5 France Sales Analysis
    • 6.4.6 Germany Sales Analysis
    • 6.4.7 Italy Sales Analysis
    • 6.4.8 Russia Sales Analysis
    • 6.4.9 Rest Of Europe Sales Analysis
  • 6.5. Asia Pacific Sales Analysis
    • 6.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.5.2 Asia Pacific By Segment Sales Analysis
    • 6.5.3 Asia Pacific By Country Sales Analysis
    • 6.5.4 China Sales Analysis
    • 6.5.5 India Sales Analysis
    • 6.5.6 Japan Sales Analysis
    • 6.5.7 South Korea Sales Analysis
    • 6.5.8 Australia Sales Analysis
    • 6.5.9 South East Asia Sales Analysis
    • 6.5.10 Rest Of Asia Pacific Sales Analysis
  • 6.6. Latin America Sales Analysis
    • 6.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.6.2 Latin America By Segment Sales Analysis
    • 6.6.3 Latin America By Country Sales Analysis
    • 6.6.4 Brazil Sales Analysis
    • 6.6.5 Argentina Sales Analysis
    • 6.6.6 Peru Sales Analysis
    • 6.6.7 Chile Sales Analysis
    • 6.6.8 Rest of Latin America Sales Analysis
  • 6.7. Middle East & Africa Sales Analysis
    • 6.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.7.2 Middle East & Africa By Segment Sales Analysis
    • 6.7.3 Middle East & Africa By Country Sales Analysis
    • 6.7.4 Saudi Arabia Sales Analysis
    • 6.7.5 UAE Sales Analysis
    • 6.7.6 Israel Sales Analysis
    • 6.7.7 South Africa Sales Analysis
    • 6.7.8 Rest Of Middle East And Africa Sales Analysis

7. COMPETITIVE LANDSCAPE OF THE BIOPHARMACEUTICAL EXCIPIENTS COMPANIES

  • 7.1. Biopharmaceutical Excipients Market Competition
  • 7.2. Partnership/Collaboration/Agreement
  • 7.3. Merger And Acquisitions
  • 7.4. New Product Launch
  • 7.5. Other Developments

8. COMPANY PROFILES OF BIOPHARMACEUTICAL EXCIPIENTS INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Market Concentration Rate
  • 8.3. Merck KGaA
    • 8.3.1 Company Overview
    • 8.3.2 Company Revenue
    • 8.3.3 Products
    • 8.3.4 Recent Developments
  • 8.4. Colorcon
    • 8.4.1 Company Overview
    • 8.4.2 Company Revenue
    • 8.4.3 Products
    • 8.4.4 Recent Developments
  • 8.5. BASF SE
    • 8.5.1 Company Overview
    • 8.5.2 Company Revenue
    • 8.5.3 Products
    • 8.5.4 Recent Developments
  • 8.6. Associated British Foods Plc
    • 8.6.1 Company Overview
    • 8.6.2 Company Revenue
    • 8.6.3 Products
    • 8.6.4 Recent Developments
  • 8.7. Signet Excipients Pvt. Ltd (IMCD)
    • 8.7.1 Company Overview
    • 8.7.2 Company Revenue
    • 8.7.3 Products
    • 8.7.4 Recent Developments
  • 8.8. Sigachi Industries Limited
    • 8.8.1 Company Overview
    • 8.8.2 Company Revenue
    • 8.8.3 Products
    • 8.8.4 Recent Developments
  • 8.9. Spectrum Chemical Manufacturing Corp.
    • 8.9.1 Company Overview
    • 8.9.2 Company Revenue
    • 8.9.3 Products
    • 8.9.4 Recent Developments
  • 8.10. Roquette FreRes
    • 8.10.1 Company Overview
    • 8.10.2 Company Revenue
    • 8.10.3 Products
    • 8.10.4 Recent Developments
  • 8.11. IMCD
    • 8.11.1 Company Overview
    • 8.11.2 Company Revenue
    • 8.11.3 Products
    • 8.11.4 Recent Developments
  • 8.12. Clariant
    • 8.12.1 Company Overview
    • 8.12.2 Company Revenue
    • 8.12.3 Products
    • 8.12.4 Recent Developments
  • 8.13. DFE Pharma
    • 8.13.1 Company Overview
    • 8.13.2 Company Revenue
    • 8.13.3 Products
    • 8.13.4 Recent Developments
  • 8.14. J. Rettenmaier & SoHne GmbH + Co KG
    • 8.14.1 Company Overview
    • 8.14.2 Company Revenue
    • 8.14.3 Products
    • 8.14.4 Recent Developments
  • 8.15. Evonik Industries AG
    • 8.15.1 Company Overview
    • 8.15.2 Company Revenue
    • 8.15.3 Products
    • 8.15.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (Tons and USD MN)
  • Solubilizes & Surfactants/Emulsifiers (Triglycerides, Esters, Others) Market Sales By Geography (Tons and USD MN)
  • Polyols (Mannitol, Sorbitol, Others) Market Sales By Geography (Tons and USD MN)
  • Carbohydrates (Sucrose, Dextrose, Starch, Others) Market Sales By Geography (Tons and USD MN)
  • Global Biopharmaceutical Excipients Market Sales By Geography (Tons and USD MN)
  • North America Market Analysis (Tons and USD MN)
  • United States Market Analysis (Tons and USD MN)
  • Canada Market Analysis (Tons and USD MN)
  • Mexico Market Analysis (Tons and USD MN)
  • Europe Market Analysis (Tons and USD MN)
  • Europe Market Estimate By Country (Tons and USD MN)
  • United Kingdom Market Analysis (Tons and USD MN)
  • France Market Analysis (Tons and USD MN)
  • Germany Market Analysis (Tons and USD MN)
  • Italy Market Analysis (Tons and USD MN)
  • Russia Market Analysis (Tons and USD MN)
  • Spain Market Analysis (Tons and USD MN)
  • Rest of Europe Market Analysis (Tons and USD MN)
  • Asia Pacific Market Analysis (Tons and USD MN)
  • China Market Analysis (Tons and USD MN)
  • Japan Market Analysis (Tons and USD MN)
  • India Market Analysis (Tons and USD MN)
  • South Korea Market Analysis (Tons and USD MN)
  • Australia Market Analysis (Tons and USD MN)
  • South East Asia Market Analysis (Tons and USD MN)
  • Rest of Asia Pacific Market Analysis (Tons and USD MN)
  • Latin America Market Analysis (Tons and USD MN)
  • Brazil Market Analysis (Tons and USD MN)
  • Argentina Market Analysis (Tons and USD MN)
  • Peru Market Analysis (Tons and USD MN)
  • Chile Market Analysis (Tons and USD MN)
  • Rest of Latin America Market Analysis (Tons and USD MN)
  • Middle East & Africa Market Analysis (Tons and USD MN)
  • Saudi Arabia Market Analysis (Tons and USD MN)
  • UAE Market Analysis (Tons and USD MN)
  • Israel Market Analysis (Tons and USD MN)
  • South Africa Market Analysis (Tons and USD MN)
  • Rest of Middle East and Africa Market Analysis (Tons and USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Biopharmaceutical Excipients Report
  • Market Research Process
  • Market Research Methodology
  • Global Biopharmaceutical Excipients Market Size, By Region (Tons and USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (Tons and USD MN)
  • Solubilizes & Surfactants/Emulsifiers (Triglycerides, Esters, Others) Market Sales By Geography (Tons and USD MN)
  • Polyols (Mannitol, Sorbitol, Others) Market Sales By Geography (Tons and USD MN)
  • Carbohydrates (Sucrose, Dextrose, Starch, Others) Market Sales By Geography (Tons and USD MN)
  • Global Market Sales (Tons and USD MN)
  • North America Market Sales (Tons and USD MN)
  • Europe Market Sales (Tons and USD MN)
  • Asia Pacific Market Sales (Tons and USD MN)
  • Latin America Market Sales (Tons and USD MN)
  • Middle East & Africa Market Sales (Tons and USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.